STOCK TITAN

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

Merit Medical Systems (MMSI) will release its third-quarter 2026 financial results after the stock market closes on October 29, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
earnings date

Merit Medical Systems (MMSI) will release its third-quarter 2026 financial results after the stock market closes on October 29, 2026. The results cover the quarter ended September 30, 2026. Merit plans to hold an investor conference call that day at 4:30 p.m. Eastern, with a live webcast and slide deck available.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

Contacts:

 
PR/Media Inquiries:
Sarah Comstock
Merit Medical
Investor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare
+1-801-432-2864+1-443-213-0509
sarah.comstock@merit.commike.piccinino@icrhealthcare.com

Keep reading